Antimicrobial prescriptions in cats in Switzerland before and after the introduction of an online antimicrobial stewardship tool.

Antibiotics Antimicrobial stewardship program Companion animals HPCIA Highest priority critically important antimicrobial One Health Prescription guidelines Prescription patterns

Journal

BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759

Informations de publication

Date de publication:
03 Jul 2020
Historique:
received: 21 10 2019
accepted: 26 06 2020
entrez: 5 7 2020
pubmed: 6 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

Antimicrobial stewardship activities are essential to improve prudent antimicrobial use. The aim of the present study was to evaluate changes in antimicrobial prescriptions in cats after the introduction of prudent use guidelines promoted by an online antimicrobial stewardship tool (AntibioticScout.ch) in Switzerland. Data from 792 cats presented to two university hospitals and 14 private practices in 2018 were included and compared to 776 cases from 2016. Cats were diagnosed with acute upper respiratory tract disease (aURTD), feline lower urinary tract disease (FLUTD) and abscesses. Clinical history, diagnostic work-up and antimicrobial prescriptions (class, dosage, duration) were assessed. Type and proportions [95% confidence intervals] of antimicrobial prescriptions were compared between the two evaluation periods and a mixed effects logistic regression model was applied to evaluate compliance with Swiss prudent use guidelines. From 2016 to 2018, the proportion of antimicrobial prescription in all included cases decreased from 75.0% [71.8-78.0] to 66.7% [63.3-69.9]; this decrease was most pronounced for treatments at university hospitals (67.1% [59.5-74.0] to 49.3% [40.9-57.8]) and for cats with FLUTD (60.1% [54.6-65.4] to 48.8% [43.2-54.4]). Use of 3rd generation cephalosporins in private practices declined from 30.7% [26.5-35.1] to 22.1% [18.4-26.2], while overall use of non-potentiated aminopenicillins increased from 19.6% [16.4-23.0] to 27.8% [24.1-31.9]. In cases where antimicrobial therapy was indicated, compliance with guidelines did not increase (33.3% [26.6-40.6] to 33.5% [27.2-40.2]), neither at universities nor in private practices. On the other hand, antimicrobial treatment was more often withheld in cases with no indication for antimicrobial therapy (35.6% [30.1-41.4] to 54.0% [47.6-60.4]); this was found for private practices (26.7% [20.8-33.4] to 46.0% [38.4-53.7]) and for aURTD cases (35.0% [26.5-44.2] to 55.4% [44.7-65.8]). Overall proportions of antimicrobial prescription, unjustified antimicrobial therapy and, in private practices, use of 3rd generation cephalosporins decreased from 2016 to 2018 for the investigated feline diseases. However, overall compliance with Swiss prudent use guidelines was still low, implying that further efforts are required to foster prudent antimicrobial use in cats.

Sections du résumé

BACKGROUND BACKGROUND
Antimicrobial stewardship activities are essential to improve prudent antimicrobial use. The aim of the present study was to evaluate changes in antimicrobial prescriptions in cats after the introduction of prudent use guidelines promoted by an online antimicrobial stewardship tool (AntibioticScout.ch) in Switzerland. Data from 792 cats presented to two university hospitals and 14 private practices in 2018 were included and compared to 776 cases from 2016. Cats were diagnosed with acute upper respiratory tract disease (aURTD), feline lower urinary tract disease (FLUTD) and abscesses. Clinical history, diagnostic work-up and antimicrobial prescriptions (class, dosage, duration) were assessed. Type and proportions [95% confidence intervals] of antimicrobial prescriptions were compared between the two evaluation periods and a mixed effects logistic regression model was applied to evaluate compliance with Swiss prudent use guidelines.
RESULTS RESULTS
From 2016 to 2018, the proportion of antimicrobial prescription in all included cases decreased from 75.0% [71.8-78.0] to 66.7% [63.3-69.9]; this decrease was most pronounced for treatments at university hospitals (67.1% [59.5-74.0] to 49.3% [40.9-57.8]) and for cats with FLUTD (60.1% [54.6-65.4] to 48.8% [43.2-54.4]). Use of 3rd generation cephalosporins in private practices declined from 30.7% [26.5-35.1] to 22.1% [18.4-26.2], while overall use of non-potentiated aminopenicillins increased from 19.6% [16.4-23.0] to 27.8% [24.1-31.9]. In cases where antimicrobial therapy was indicated, compliance with guidelines did not increase (33.3% [26.6-40.6] to 33.5% [27.2-40.2]), neither at universities nor in private practices. On the other hand, antimicrobial treatment was more often withheld in cases with no indication for antimicrobial therapy (35.6% [30.1-41.4] to 54.0% [47.6-60.4]); this was found for private practices (26.7% [20.8-33.4] to 46.0% [38.4-53.7]) and for aURTD cases (35.0% [26.5-44.2] to 55.4% [44.7-65.8]).
CONCLUSIONS CONCLUSIONS
Overall proportions of antimicrobial prescription, unjustified antimicrobial therapy and, in private practices, use of 3rd generation cephalosporins decreased from 2016 to 2018 for the investigated feline diseases. However, overall compliance with Swiss prudent use guidelines was still low, implying that further efforts are required to foster prudent antimicrobial use in cats.

Identifiants

pubmed: 32620170
doi: 10.1186/s12917-020-02447-8
pii: 10.1186/s12917-020-02447-8
pmc: PMC7333330
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

229

Subventions

Organisme : Swiss National Science Foundation
ID : NRP72 grant 407240_167054
Pays : Switzerland

Références

Vet Ophthalmol. 2016 Jul;19 Suppl 1:119-30
pubmed: 27091747
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Vet J. 2019 May;247:8-25
pubmed: 30971357
Acta Vet Scand. 2017 Dec 11;59(1):81
pubmed: 29228960
Schweiz Arch Tierheilkd. 2016 Dec;158(12):805-810
pubmed: 27934622
Vet J. 2017 Jun;224:18-24
pubmed: 28697871
Emerg Infect Dis. 2016 Sep;22(9):1679-81
pubmed: 27191649
J Feline Med Surg. 2005 Aug;7(4):241-2
pubmed: 16055011
Ann Emerg Med. 2015 Jan;65(1):112-3
pubmed: 25199614
Vet Microbiol. 2014 Jul 16;171(3-4):269-72
pubmed: 24852141
J Feline Med Surg. 2005 Feb;7(1):33-41
pubmed: 15686972
Prev Vet Med. 2014 Nov 1;117(1):68-78
pubmed: 25091861
J Vet Intern Med. 2017 Jul;31(4):1100-1107
pubmed: 28514013
J Glob Antimicrob Resist. 2013 Jun;1(2):55-62
pubmed: 27873579
J Antimicrob Chemother. 2017 Nov 1;72(11):3205-3212
pubmed: 28961815
Vet Rec. 2014 Oct 4;175(13):325
pubmed: 24899065
J Am Vet Med Assoc. 2001 May 1;218(9):1429-35
pubmed: 11345305
BMC Vet Res. 2019 Mar 14;15(1):94
pubmed: 30871537
Front Vet Sci. 2018 Mar 27;5:62
pubmed: 29662886
Vet Rec. 2016 Nov 12;179(19):486-488
pubmed: 27837070
Vet Rec. 2016 Dec 24;179(25):651
pubmed: 27807211
Schweiz Arch Tierheilkd. 2017 Oct;159(10):525-533
pubmed: 28952960
Ann Emerg Med. 2007 Jul;50(1):49-51
pubmed: 17577944
J Vet Intern Med. 2015 Mar-Apr;29(2):487-98
pubmed: 25783842
Vet Rec. 2018 Mar 17;182(11):324
pubmed: 29196488
Vet Rec. 2016 Nov 12;179(19):489
pubmed: 27543064
Med Care. 2008 Aug;46(8):847-62
pubmed: 18665065
Scand J Infect Dis. 2014 Apr;46(4):310-4
pubmed: 24450843
Microbiol Spectr. 2018 May;6(3):
pubmed: 29916349
J Small Anim Pract. 2005 Dec;46(12):571-7
pubmed: 16355731
J Feline Med Surg. 2011 Jun;13(6):410-7
pubmed: 21440473
J Antimicrob Chemother. 2011 Jun;66(6):1223-30
pubmed: 21460369
J Am Vet Med Assoc. 2006 Feb 15;228(4):553-8
pubmed: 16478430
Microbiol Spectr. 2018 Mar;6(2):
pubmed: 29600770
Vet Clin North Am Small Anim Pract. 2015 Mar;45(2):361-76, vii
pubmed: 25721619
J Clin Pharm Ther. 2010 Feb;35(1):71-8
pubmed: 20175814
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Can Vet J. 2012 Mar;53(3):291-8
pubmed: 22942447
J Feline Med Surg. 2007 Dec;9(6):458-65
pubmed: 17693110
Vet Microbiol. 2004 Jan 14;98(1):23-7
pubmed: 14738778
Vet Rec. 2001 May 5;148(18):567-72
pubmed: 11370882
Prev Vet Med. 2018 Oct 1;158:106-113
pubmed: 30220383
Antimicrob Agents Chemother. 2007 Nov;51(11):4044-8
pubmed: 17846141
Vet Rec. 2013 Nov 16;173(19):475
pubmed: 24068699
BMC Public Health. 2014 Dec 15;14:1276
pubmed: 25511932
J Antimicrob Chemother. 2004 Aug;54(2):321-32
pubmed: 15254022
Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; discussion S62-70
pubmed: 16735147
Zoonoses Public Health. 2011 Dec;58(8):533-9
pubmed: 21824350
Vet Microbiol. 2018 Nov;225:34-39
pubmed: 30322530
PLoS One. 2010 Nov 16;5(11):e14011
pubmed: 21103362
Br J Gen Pract. 2013 Jul;63(612):e445-54
pubmed: 23834881

Auteurs

Alina Hubbuch (A)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.

Kira Schmitt (K)

Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 272, CH-8057, Zurich, Switzerland.

Claudia Lehner (C)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Länggassstrasse 128, CH-3012, Bern, Switzerland.

Sonja Hartnack (S)

Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 270, CH-8057, Zurich, Switzerland.

Simone Schuller (S)

Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Länggassstrasse 128, CH-3012, Bern, Switzerland.

Gertraud Schüpbach-Regula (G)

Veterinary Public Health Institute (VPHI), Vetsuisse Faculty, University of Bern, Schwarzenburgstrasse 161, CH-3097, Liebefeld, Switzerland.

Meike Mevissen (M)

Division of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, CH-3012, Bern, Switzerland.

Ruth Peter (R)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.

Cedric Müntener (C)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.

Hanspeter Naegeli (H)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland. hanspeter.naegeli@vetpharm.uzh.ch.

Barbara Willi (B)

Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland. bwilli@vetclinics.uzh.ch.

Articles similaires

Humans Child Nervous System Diseases Adolescent Polypharmacy
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH